<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Increasing numbers of patients are being treated with immunomodulators (<z:chebi fb="1" ids="16069">IMD</z:chebi>) for <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) and autoimmune <z:hpo ids='HP_0012115'>hepatitis</z:hpo> (AIH) </plain></SENT>
<SENT sid="1" pm="."><plain>This needs intensive monitoring and impacts by increasing clinic waiting times </plain></SENT>
<SENT sid="2" pm="."><plain>After approval from the Quality and Safety Board of the Trust, a pharmacist led <z:chebi fb="1" ids="16069">IMD</z:chebi> clinic was established in 2012 to manage patients initiated on <z:chebi fb="1" ids="16069">IMD</z:chebi> for initial monitoring and dose titration with a view to reduced clinic visits </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Patients were referred to the pharmacist led clinic by the gastroenterologists and IBD nurse specialist for commencing and monitoring of <z:chebi fb="1" ids="16069">IMD</z:chebi> after initial counselling </plain></SENT>
<SENT sid="4" pm="."><plain>Screening blood tests including the TPMT assay were checked prior to commencing the <z:chebi fb="1" ids="16069">IMD</z:chebi> as per agreed protocol </plain></SENT>
<SENT sid="5" pm="."><plain>The pharmacist issued prescriptions and patients were given blood forms for weekly tests for the initial two months, fortnightly for the next two months and three monthly thereafter </plain></SENT>
<SENT sid="6" pm="."><plain>Results were monitored by the pharmacist and patients were offered a choice of telephone or email consultations with the pharmacist for subsequent appointments </plain></SENT>
<SENT sid="7" pm="."><plain>The pharmacist had easy access to advice from the clinician in the event of adverse effects </plain></SENT>
<SENT sid="8" pm="."><plain>After initial stabilisation patients were referred back to the GP or the referring clinician for follow up </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: 81 patients were referred to the pharmacist led <z:chebi fb="1" ids="16069">IMD</z:chebi> clinic between October 2012-2013 [(50F); Median age 44 (range 19-76)] </plain></SENT>
<SENT sid="10" pm="."><plain>Indications for treatment were IBD (n = 73) [<z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (n = 33), Crohn's (n = 40)] and AIH (n = 8) </plain></SENT>
<SENT sid="11" pm="."><plain>Twenty seven patients (33.3%) experienced side effects between weeks 2 to 6 of initiation of treatment </plain></SENT>
<SENT sid="12" pm="."><plain>These were <z:hpo ids='HP_0002018'>nausea</z:hpo> or <z:hpo ids='HP_0002013'>vomiting</z:hpo> 16% (n = 13), <z:hpo ids='HP_0000988'>skin rash</z:hpo> 1% (n = 1), <z:mp ids='MP_0002899'>fatigue</z:mp> 1% (n = 1),<z:hpo ids='HP_0003326'>myalgia</z:hpo> 1% (n = 1), intolerance 1% (n = 1) and stomach cramps 1% (n = 1) </plain></SENT>
<SENT sid="13" pm="."><plain>Abnormal blood tests were noted in 23.4% (n = 19) patients </plain></SENT>
<SENT sid="14" pm="."><plain>These were abnormal liver tests [predominantly transaminitis] (n = 11); myelosupression (n = 6) </plain></SENT>
<SENT sid="15" pm="."><plain>Six patients were admitted to hospital [<z:e sem="disease" ids="C0854467" disease_type="Disease or Syndrome" abbrv="">myelosuppression</z:e> n = 2, <z:hpo ids='HP_0001733'>pancreatitis</z:hpo> n = 1, unrelated to <z:chebi fb="1" ids="16069">IMD</z:chebi> n = 3] </plain></SENT>
<SENT sid="16" pm="."><plain>Management of adverse events included changing to an alternative agent (n = 13), dose adjustment (n = 12) and discontinuation of <z:chebi fb="1" ids="16069">IMD</z:chebi> (n = 10) </plain></SENT>
<SENT sid="17" pm="."><plain>CONCLUSION: A pharmacist-led clinic is a safe alternative to conventional gastroenterology clinics for monitoring of patients on <z:chebi fb="1" ids="16069">IMD</z:chebi> </plain></SENT>
<SENT sid="18" pm="."><plain>Adverse events were picked up early and adequately acted upon </plain></SENT>
<SENT sid="19" pm="."><plain>There was a high level of patient compliance and reduced number of clinic visits; the average numbers of clinic visits saved were 10 per patient </plain></SENT>
<SENT sid="20" pm="."><plain>REFERENCES: Jenkins J, British Journal of Clinical Pharmacy </plain></SENT>
<SENT sid="21" pm="."><plain>1:219-220 Das J, Hospital Pharmacist </plain></SENT>
<SENT sid="22" pm="."><plain>January 2008 DISCLOSURE OF INTEREST: None Declared </plain></SENT>
</text></document>